Sionna Therapeutics, Inc. (SION) Gets a Buy from TD Cowen
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Sionna Therapeutics, Inc. (SION – Research Report). The ...
Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month
The average price target suggests a potential upside of 132.91% from the latest price. Overall, SION ranks 4th on our list of top insider purchases last month. While we acknowledge the potential of ...
TD Cowen Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)
TD Cowen analyst Ritu Baral maintained a Buy rating on Sionna Therapeutics, Inc. (SION – Research Report) today. The company’s shares opened ...
Sionna Therapeutics (NASDAQ:SION) Hits New 12-Month Low on Disappointing Earnings
Shares of Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report) hit a new 52-week low on Friday following a dissappointing earnings announcement. The company traded as low as $12.46 and last ...